Atlas Trials

A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer

Clinical trial NCT07474142 · RECRUITING

Trial details

NCT number
NCT07474142
Sponsor
Xijing Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Newly Diagnosed, Treatment-naïve Prostate Cancer
Start date
2026-03-03
Primary completion
2028-03-03
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.